Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $360,260 - $451,792
497 New
497 $452,000
Q2 2023

Sep 26, 2023

SELL
$350.74 - $468.98 $522,251 - $698,311
-1,489 Reduced 75.09%
494 $232,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $236,700 - $277,992
-762 Reduced 27.76%
1,983 $680,000
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $6,752 - $7,868
-21 Reduced 0.76%
2,745 $1.01 Million
Q3 2022

Nov 16, 2022

SELL
$296.48 - $337.87 $7,412 - $8,446
-25 Reduced 0.9%
2,766 $894,000
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $43,203 - $50,726
155 Added 5.88%
2,791 $905,000
Q1 2022

May 24, 2022

BUY
$234.69 - $291.66 $618,642 - $768,815
2,636 New
2,636 $755,000
Q2 2021

Aug 19, 2021

SELL
$180.55 - $233.54 $602,495 - $779,322
-3,337 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $548,335 - $709,846
3,337 New
3,337 $623,000
Q2 2019

Aug 16, 2019

SELL
$110.79 - $129.32 $326,719 - $381,364
-2,949 Closed
0 $0
Q1 2019

May 17, 2019

SELL
$111.31 - $131.02 $29,831 - $35,113
-268 Reduced 8.33%
2,949 $383,000
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $105 - $118
1 Added 0.03%
3,217 $372,000
Q3 2018

Nov 16, 2018

BUY
$85.86 - $107.31 $38,980 - $48,718
454 Added 16.44%
3,216 $345,000
Q2 2018

Aug 17, 2018

SELL
$75.7 - $86.88 $151 - $173
-2 Reduced 0.07%
2,762 $236,000
Q1 2018

May 18, 2018

BUY
$74.21 - $87.6 $21,966 - $25,929
296 Added 11.99%
2,764 $214,000
Q4 2017

Feb 15, 2018

SELL
$81.94 - $87.89 $31,464 - $33,749
-384 Reduced 13.46%
2,468 $724,000
Q3 2017

Nov 15, 2017

BUY
$77.07 - $85.54 $770 - $855
10 Added 0.35%
2,852 $244,000
Q2 2017

Aug 22, 2017

BUY
N/A
2,842
2,842 $234,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.